Menu
GeneBe

rs771614642

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2

The NM_001754.5(RUNX1):c.749G>A(p.Arg250His) variant causes a missense change. The variant allele was found at a frequency of 0.0000571 in 1,611,146 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R250C) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 31)
Exomes 𝑓: 0.000058 ( 0 hom. )

Consequence

RUNX1
NM_001754.5 missense

Scores

5
11
3

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:7

Conservation

PhyloP100: 4.54
Variant links:
Genes affected
RUNX1 (HGNC:10471): (RUNX family transcription factor 1) Core binding factor (CBF) is a heterodimeric transcription factor that binds to the core element of many enhancers and promoters. The protein encoded by this gene represents the alpha subunit of CBF and is thought to be involved in the development of normal hematopoiesis. Chromosomal translocations involving this gene are well-documented and have been associated with several types of leukemia. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BS2
High AC in GnomAd at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
RUNX1NM_001754.5 linkuse as main transcriptc.749G>A p.Arg250His missense_variant 7/9 ENST00000675419.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
RUNX1ENST00000675419.1 linkuse as main transcriptc.749G>A p.Arg250His missense_variant 7/9 NM_001754.5 A1Q01196-8

Frequencies

GnomAD3 genomes
AF:
0.0000463
AC:
7
AN:
151250
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0000244
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000659
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000737
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000400
AC:
10
AN:
250026
Hom.:
0
AF XY:
0.0000370
AC XY:
5
AN XY:
135070
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000799
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000582
AC:
85
AN:
1459896
Hom.:
0
Cov.:
32
AF XY:
0.0000551
AC XY:
40
AN XY:
725814
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000232
Gnomad4 FIN exome
AF:
0.0000375
Gnomad4 NFE exome
AF:
0.0000648
Gnomad4 OTH exome
AF:
0.000133
GnomAD4 genome
AF:
0.0000463
AC:
7
AN:
151250
Hom.:
0
Cov.:
31
AF XY:
0.0000542
AC XY:
4
AN XY:
73814
show subpopulations
Gnomad4 AFR
AF:
0.0000244
Gnomad4 AMR
AF:
0.0000659
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000737
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000387
Hom.:
0
Bravo
AF:
0.0000642
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000259
AC:
1
ExAC
AF:
0.0000494
AC:
6
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary thrombocytopenia and hematological cancer predisposition syndrome associated with RUNX1 Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingInvitaeJan 01, 2024This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 250 of the RUNX1 protein (p.Arg250His). This variant is present in population databases (rs771614642, gnomAD 0.007%). This missense change has been observed in individual(s) with acute lymphoblastic leukemia (PMID: 34166225). ClinVar contains an entry for this variant (Variation ID: 239055). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RUNX1 protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change does not substantially affect RUNX1 function (PMID: 34166225). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Uncertain significance, criteria provided, single submitterclinical testingSt. Jude Molecular Pathology, St. Jude Children's Research HospitalJan 12, 2021- -
Acute myeloid leukemia Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingJohns Hopkins Genomics, Johns Hopkins UniversityAug 17, 2020This RUNX1 variant (rs771614642) is rare (<0.1%) in a large population dataset (gnomAD: 11/281252 total alleles; 0.004%; no homozygotes) and has not been reported in the literature, to our knowledge. RUNX1 c.749G>A has been reported in ClinVar. Of two bioinformatics tools queried, one predicts that the substitution would be damaging, while the other predicts that it would be tolerated. Due to insufficient evidence, we consider its clinical significance uncertain at this time. -
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsJul 01, 2023- -
not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoOct 31, 2019- -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingGeneDxJul 09, 2023Published functional studies demonstrate no damaging effect: no significant impact on transactivation activity, DNA binding function, beta-subunit interaction, or subcellular localization (Koh et al., 2013; Li et al., 2021); Identified in the germline of individuals with acute lymphoblastic leukemia (Li et al., 2021); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as R223H; This variant is associated with the following publications: (PMID: 23817177, 34166225) -
RUNX1-related condition Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact SciencesFeb 09, 2023The RUNX1 c.749G>A variant is predicted to result in the amino acid substitution p.Arg250His. This variant, also described as p.Arg223His (R223H) in an alternative transcript, has been reported as a germline variant in two individuals with pediatric B cell acute lymphoblastic leukemia (B-ALL) and in a 12-year-old patient with thrombocytopenia and myelodysplastic syndrome (MDS) who had refractory cytopenia in childhood (Table 1, Li Y et al 2021. PubMed ID: 34166225; Figure 2, Decker M et al 2022. PubMed ID: 35026845). This variant was also reported as an incidental finding in an individual with Larsen syndrome who did not have thrombocytopenia or abnormal whole blood cell counts (Figure 2, Decker M et al 2022. PubMed ID: 35026845). In vitro functional studies suggest that DNA binding, β-subunit interaction, subcellular localization, and transcriptional activity for this variant are similar to control (Table 1, Koh CP et al 2013. PubMed ID: 23817177; Figure 2, Li Y et al 2021. PubMed ID: 34166225; Figure 1, Decker M et al 2022. PubMed ID: 35026845). This variant is reported in 0.0070% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/21-36206763-C-T) and is interpreted as uncertain in ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/variation/239055/?new_evidence=true). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Uncertain
0.12
D
BayesDel_noAF
Uncertain
0.13
Cadd
Pathogenic
28
Dann
Pathogenic
1.0
DEOGEN2
Pathogenic
0.86
D;.;.;.;.
Eigen
Pathogenic
0.69
Eigen_PC
Uncertain
0.65
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.95
D;D;.;D;D
M_CAP
Pathogenic
0.71
D
MetaRNN
Uncertain
0.72
D;D;D;D;D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.4
M;.;.;M;.
MutationTaster
Benign
0.92
D;D;D;D;D;D
PrimateAI
Uncertain
0.77
T
PROVEAN
Uncertain
-3.3
D;D;D;D;D
REVEL
Uncertain
0.49
Sift
Uncertain
0.0030
D;D;D;D;D
Sift4G
Benign
0.11
T;T;T;T;.
Polyphen
1.0
D;D;D;D;.
Vest4
0.58
MVP
0.98
MPC
0.83
ClinPred
0.67
D
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.36
gMVP
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs771614642; hg19: chr21-36206763; COSMIC: COSV55881639; COSMIC: COSV55881639; API